NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The nuclear factor NF-kappaB and oncogenic Ras can alter proliferation in epidermis, the most common site of human cancer. These proteins are implicated in epidermal squamous cell carcinoma in mice, however, the potential effects of altering their function are uncertain. Whereas inhibition of NF-kappaB enhances apoptosis in certain tumours, blockade of NF-kappaB predisposes murine skin to squamous cell carcinoma. Because therapeutics inhibiting Ras and NF-kappaB pathways are being developed to treat human cancer, it is essential to assess the effects of altering these regulators. The medical relevance of murine studies is limited, however, by differences between mouse and human skin, and by the greater ease of transforming murine cells. Here we show that in normal human epidermal cells both NF-kappaB and oncogenic Ras trigger cell-cycle arrest. Growth arrest triggered by oncogenic Ras can be bypassed by IkappaBalpha-mediated blockade of NF-kappaB, generating malignant human epidermal tissue resembling squamous cell carcinoma. Human cell tumorigenesis is dependent on laminin 5 and alpha6beta4 integrin. Thus, IkappaBalpha circumvents restraints on growth promotion induced by oncogenic Ras and can act with Ras to induce invasive human tissue neoplasia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“upon cotransfection with the human TERT gene, defined sets of oncogenes, specifically activated H-RAS, SV40 large T antigen and SV40 small t antigen, resulted in the efficient malignant transformation of human fibroblasts (96).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [96]
Citations
Cites
Dermatology in General Medicine.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-6-923_2 · Cited by 3,794
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Suppression of TNF-α-Induced Apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., & Greenberg, M. E. (1999) · Science · doi:10.1126/science.286.5443.1358 · Cited by 1,901
Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
Yamamoto, Y., & Gaynor, R. B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11914 · Cited by 1,585
Cutaneous Squamous-Cell Carcinoma
Alam, M., & Ratner, D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441306 · Cited by 1,305
Nonmelanoma skin cancer in the United States: Incidence
Miller, D. L., & Weinstock, M. A. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(08)81509-5 · Cited by 1,098 · cited 1×
“jpg" NDATA ITEM> ]> The nuclear factor NF-κB and oncogenic Ras can alter proliferation in epidermis, the most common site of human cance”
BackgroundHuman breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells
Elenbaas, B., Spirio, L., Koerner, F., Fleming, M. D., Zimonjic, D. B., Donaher, J. L., Popescu, N. C., Hahn, W. C., & Weinberg, R. A. (2001) · Genes & Development · doi:10.1101/gad.828901 · Cited by 878 · cited 1×
“Ectopic subcutaneous tumour formation in mice often requires administration of matrigel or fibroblast-derived matri”
BackgroundBlocking Oncogenic Ras Signaling for Cancer Therapy
Adjei, A. A. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1062 · Cited by 831 · cited 1×
“Because therapeutics inhibiting Ras and NF-κB pathways are being developed to treat human cance”
Background
Cited by
Items 401–500 of 540
An Anchor for Tumor Cell Invasion
Yuspa, S. H., & Epstein, E. H. (2005) · Science · doi:10.1126/science.1110346 · Cited by 12
The Transcription Factor NF-κB as Drug Target
Haefner, B. (2005) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(05)43005-2 · Cited by 13
Yorkie-Cactus (IκBα)-JNK axis promotes tumor growth and progression in Drosophila
Snigdha, K., Singh, A., & Kango-Singh, M. (2021) · Oncogene · doi:10.1038/s41388-021-01831-4 · Cited by 11
Chen, Q., Du, X., Hu, S., & Huang, Q. (2022) · BioMed Research International · doi:10.1155/2022/5092505 · Cited by 11
“This contradiction may be concerned in NF-κ B ’ s bidirectional regulation of tumor [6, 8, 35, 36].”
Identification and functional validation of therapeutic targets for malignant melanoma
Gremel, G., Rafferty, M., Lau, T. Y. K., & Gallagher, W. M. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.02.004 · Cited by 13
“[58] Dajee M, Lazarov M, Zhang JY, et al.”
BackgroundMethodLiu, G., Wu, D., Liang, X.-Q., YUE, H., & Cui, Y. (2015) · Oncology Reports · doi:10.3892/or.2015.4193 · Cited by 11
Wiseman, A. (2004) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2004.09.006 · Cited by 11
Tissue-Predisposition to Cancer Driver Mutations
Peters, L., Venkatachalam, A., & Ben‐Neriah, Y. (2024) · Cells · doi:10.3390/cells13020106 · Cited by 10
“This effect appears to be tissue-specific, as in a mouse model of RAS -driven human skin cancer, NF-κ B inhibition led to tumor progression, possibly due to the role of NF-κ B in a tumor’s immunogenicity [50].”
BackgroundNF-κB-Dependent and -Independent (Moonlighting) IκBα Functions in Differentiation and Cancer
Espinosa, L., & Marruecos, L. (2021) · Biomedicines · doi:10.3390/biomedicines9091278 · Cited by 10
“Moreover, co-expression of IκBα-SR with mutant KRAS (G12V) increased tumor invasiveness [74].”
BackgroundSquamous Cell Carcinoma and its Precursors
Gupta, G., Madan, V., & Lear, J. T. (2016) · Wiley eBooks · doi:10.1002/9781118441213.rtd0143 · Cited by 13
Schwarz, M., Thielmann, H. W., Meischner, V., & Fartasch, M. (2015) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2015.03.014 · Cited by 9
Renaldi, K., Marcellus Simadibrata, K., Rahadiani, N., Handjari, D. R., Harahap, A. R., Harimurti, K., Zubir, N., Siregar, L., Loho, I. M., Suzanna, E., et al. (2023) · Pathophysiology · doi:10.3390/pathophysiology30020009 · Cited by 9
“Several in vitro and animal studies have shown that NF−κB activation could lead to tumorigenesis [37,38].”
BackgroundLi, X., Gao, Y., Zhou, H., Xu, W., Li, P., Zhou, J., Xu, T., Yu, B., Xu, Z., Zou, Q., et al. (2016) · Cancer Biomarkers · doi:10.3233/cbm-150536 · Cited by 9
“In recent years, a growing number of evidence suggests the involvement of NF-κB in linking inflammation to oncogenesis and progression [12–15].”
BackgroundMECHANISMS OF MICROVASCULAR WOUND REPAIR I. ROLE OF MITOSIS, OXYGEN TENSION, AND I-KAPPA B
Chaudhuri, V., Potts, B. R., & Karasek, M. A. (2006) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1290/0607043.1 · Cited by 9
“In keratinocytes, retroviral transfection with I- B also increased growth (Dajee et al., 2003).”
BackgroundWinn Aung, U., Tsuji, A. B., Sudo, H., Sugyo, A., Furukawa, T., Ukai, Y., Kurosawa, Y., & Saga, T. (2016) · Molecular Imaging · doi:10.1177/1536012115624917 · Cited by 9
Dichotomy of Notch signalling in regulating tumour immune surveillance
Khosla, R., Vyas, A. K., & Trehanpati, N. (2018) · Scandinavian Journal of Immunology · doi:10.1111/sji.12744 · Cited by 9
“Blocking of NF‐kB was shown to trigger invasive human epidermal neoplasia through TNF/JNK activity.(111) Since Notch activation leads to induction of NF‐κB(112) it is quite possible that the tumour suppressing function of Notch in this case is mediated by NF‐κB.”
BackgroundSimões, R. T., Gonçalves, M. A. G., Donadi, E. A., Simões, A. L., Bettini, J. S. R., Duarte, G. G., Quintana, S. M., Carvalho, M., & Soares, E. G. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.8.3932-3937.2005 · Cited by 9
“TNF- can also contribute to the tumorigenesis process, due to the activation and induction of the expression of genes involved in proliferation, invasion, and tumor cell spreading (1, 12 ).”
BackgroundBolotin, D., & Fuchs, E. V. (2003) · Nature · doi:10.1038/421594a · Cited by 10
Molecular and cellular dynamics of squamous cell carcinomas across tissues
Kudelka, M. R., Lavin, Y., Sun, S., & Fuchs, E. V. (2024) · Genes & Development · doi:10.1101/gad.351990.124 · Cited by 10
Plectin: Dual Participation in Tumor Progression
Wang, Z., Wang, W., Luo, Q., & Song, G. (2024) · Biomolecules · doi:10.3390/biom14091050 · Cited by 8
“However, later in tumor development, the presence of oncogenes such as Ras can shift plectin’s role to one of promoting tumor growth through the Erk pathway [76,81].”
BackgroundDoukas, P. G., Vageli, D. P., & Judson, B. L. (2022) · The Laryngoscope · doi:10.1002/lary.30284 · Cited by 8
Delineating Molecular Mechanisms of Squamous Tissue Homeostasis and Neoplasia: Focus on p63
King, K. E., Ha, L., Camilli, T. C., & Weinberg, W. C. (2013) · Journal of Skin Cancer · doi:10.1155/2013/632028 · Cited by 8
Clinical significance of SQSTM1/P62 and nuclear factor-κB expression in pancreatic carcinoma
Zhang, Z.-Y., Guo, S., Zhao, R., Ji, Z., & Zhuang, Z. (2020) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v12.i7.719 · Cited by 8
A tan in a test tube –in vitro models for investigating ultraviolet radiation–induced damage in skin
Fernandez, T. L., Dawson, R., Lonkhuyzen, D. R. V., Kimlin, M. G., & Upton, Z. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01485.x · Cited by 11
Molecular tumorigenesis of the skin
Kubo, Y., Matsudate, Y., Fukui, N., Nakasuka, A., Sogawa, M., Oshima, M., Mizutani, T., Otsu, M., Murao, K., & Hashimoto, I. (2014) · The Journal of Medical Investigation · doi:10.2152/jmi.61.7 · Cited by 8
Self-citationRibozyme-Mediated Targeting of IκBγ Inhibits Melanoma Invasion and Metastasis
Torabian, S. Z., de Semir, D., Nosrati, M., Bagheri, S., Dar, A. A., Fong, S., Liu, Y., Federman, S. M., Simko, J. P., Haqq, C., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080207 · Cited by 9
Transposon-based mutagenesis identifies short RIP1 as an activator of NFκB
Dasgupta, M., Agarwal, M. K., Varley, P., Lu, T., Stark, G. R., & Kandel, E. (2008) · Cell Cycle · doi:10.4161/cc.7.14.6310 · Cited by 10
Yun, C., Chung, D. K., Yoon, K., & Han, S. H. (2006) · Toxicology Letters · doi:10.1016/j.toxlet.2005.11.009 · Cited by 8
Brutscher, F., Germani, F., Hausmann, G., Jutz, L., & Basler, K. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003068 · Cited by 8
Ling, J., Sckaff, M., Tiwari, M., Chen, Y., Li, J., Jones, J., & Sen, G. L. (2020) · Journal of Cell Science · doi:10.1242/jcs.249102 · Cited by 7
“One such pathway, the MAPK cascade is mutated in 30% of all cancers and is the most frequently activated pathway in SCC (Cheng and Tian, 2017; Dajee et al., 2003).”
BackgroundJave‐Suárez, L. F., Garcia-Becerra, N., & Aguilar‐Lemarroy, A. (2022) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520622666220509180606 · Cited by 8
Genetic Predisposition to Cutaneous Squamous Cell Carcinoma
Ng, Y.-Z., Jasbani, H. S., & Andrew, P. (2011) · InTech eBooks · doi:10.5772/26714 · Cited by 7
“In laboratories, expression of oncogenic RAS in human keratinocytes was able to recapitulate tumours in mice (Boukamp et al., 1990; Dajee et al., 2003).”
BackgroundAssociation Between MALAT1 and THRIL Polymorphisms and Precancerous Cervical Lesions
Wang, Y., Liu, Y., Li, Z., Yan, X., Huang, C., Ye, X., Sun, X., Qin, S., Zhong, X., Zeng, C., et al. (2018) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2018.0097 · Cited by 7
“The inhibition of NF-j B could induce the proliferation of epithelial cell and stimulate the development of squamous cell carcinoma (Dajee et al. , 2003).”
Reuter, J., & Khavari, P. A. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)07054-0 · Cited by 7
Self-citationEffects of IκB kinase α on the differentiation of squamous carcinoma cells
Nakayama, H., Ikebe, T., & Shirasuna, K. (2005) · Oral Oncology · doi:10.1016/j.oraloncology.2005.03.013 · Cited by 7
Really interesting new gene finger protein 121 is a tumor suppressor of renal cell carcinoma
Xiang, P., Sun, Y., Liu, Y., Shu, Q., & Zhu, Y. (2018) · Gene · doi:10.1016/j.gene.2018.08.067 · Cited by 7
Lee, A. J., Fraser, E., Flowers, B. M., Kim, J., Wong, K., Cataisson, C., Liu, H., Yang, H. H., Lee, M. P., Yuspa, S. H., et al. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23351 · Cited by 7
“Additional reports of pathways associated with RAS induced senescence in keratinocytes include ID1,(37) CEBP‐β,(38) ΔNp63α,(39,40) PRAK,(41) PPARβ/δ,(42) and NF‐κB.(43) It is not surprising”
BackgroundLaminins and Cancer Progression
Jourquin, J., Tripathi, M., Guess, C. M., & Quaranta, V. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0814-8_5 · Cited by 7
Villanueva, D. A., Floor, M., Solé, L., Palma, L. G., Maqueda, M., Bertran, J., Lobo‐Jarne, T., Rajbhandari, R., Merati, A., Marruecos, L., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115949 · Cited by 6
Saeed, S., Hassan, A. F., Suliman, A., Moustafa, A. A., & Alali, F. Q. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020654 · Cited by 7
Novel functions of chromatin-bound IκBα in oncogenic transformation
Espinosa, L., Bigas, A., & Mulero, M. C. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.84 · Cited by 7
“…of different mice strains ectopically expressing the IkBa super-repressor mutant (IkBa-SR), which develop SCC-resembling tumours in the skin (Dajee et al, 2003; van Hogerlinden et al, 1999, 2004; Table 1), what contrast with the dogma that constitutive NF-kB activation results in…”
BackgroundRETRACTED: Tumorigenic study on hepatocytes coexpressing SV40 with Ras
Sun, B., Chen, M., Hawks, C. L., Hornsby, P. J., & Wang, X. (2005) · Molecular Carcinogenesis · doi:10.1002/mc.20137 · Cited by 6
RetractedSur, I., Ulvmar, M. H., Jungedal, R., & Toftgård, R. (2009) · Journal of Receptors and Signal Transduction · doi:10.1080/10799890802679876 · Cited by 6
Chen, L. L., Gabarra, V., Cho, S. K.-W., Browning, B., Cao, X., Huet, H. A., Cheung, A. E., Morena, R. A., Ramirez, M., Shields, M. J., et al. (2008) · Cell Communication & Adhesion · doi:10.1080/15419060802428356 · Cited by 7
“As ASC-3 was previously shown to block tumor growth in vivo in a squamous carcinoma model (Dajee et al. 2003), these combined data suggest that ancho- rage-independent survival of some tumor cell types is in part a6b4-dependent.”
BackgroundKariya, Y., Oyama, M., Ohtsuka, M., Kikuchi, N., Hashimoto, Y., & Yamamoto, T. (2020) · FUKUSHIMA JOURNAL OF MEDICAL SCIENCE · doi:10.5387/fms.2020-12 · Cited by 6
Meunier, C., Kraak, L. V. D., Turbide, C., Groulx, N., Labouba, I., Cingolani, P., Blanchette, M., Yeretssian, G., Mes‐Masson, A., Saleh, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058733 · Cited by 6
The mendelian randomized study revealed the association of prostatitis with prostate cancer risk
Chen, J., Fan, Y., Shang, K., Li, N., Li, C., & He, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-76355-4 · Cited by 6
TLR3 activation mediates partial epithelial-to-mesenchymal transition in human keratinocytes
Schneider, A. M., Feehan, R. P., Sennett, M. L., Wills, C. A., Garner, C., Cong, Z., Billingsley, E. M., Flamm, A. F., Shantz, L. M., & Nelson, A. M. (2024) · Life Science Alliance · doi:10.26508/lsa.202402777 · Cited by 5
“Although the exact contribution of NF-κ B signaling in cSCCs is unclear (Dajee et al, 2003; Zhang et al, 2004; Kim & Pasparakis, 2014; Watt et al, 2015), our data support the idea that TLR3-mediated NF-κ B activation in normal keratinocytes promotes EMT, as blocking NF-κ B activity attenuates the…”
BackgroundSquamous Cell Carcinoma of the Lip
Salama, A. (2013) · Springer eBooks · doi:10.1007/978-3-642-38180-5_4 · Cited by 5
Activation of Liver X Receptors Prevents Statin-induced Death of 3T3-L1 Preadipocytes
Madsen, L., Petersen, R. K., Steffensen, K. R., Pedersen, L. M., Hallenborg, P., Ma, T., Frøyland, L., Døskeland, S. O., Gustafsson, J.-Α., & Kristiansen, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800720200 · Cited by 8
Apoptotic signaling through reactive oxygen species in cancer cells
Kim, D., Park, G. B., & Hur, D. Y. (2014) · World Journal of Immunology · doi:10.5411/wji.v4.i3.158 · Cited by 5
Nucleoporin downregulation modulates progenitor differentiation independent of nuclear pore numbers
Neely, A. E., Zhang, Y., Blumensaadt, L. A., Mao, H., Brenner, B., Sun, C., Zhang, H. F., & Bao, X. (2023) · Communications Biology · doi:10.1038/s42003-023-05398-6 · Cited by 5
Oncogenic Ras: A double-edged sword for human epidermal stem and transient amplifying cells
Dellambra, E. (2016) · Small GTPases · doi:10.1080/21541248.2016.1182242 · Cited by 4
RasGRP1 induces autophagy and transformation-associated changes in primary human keratinocytes
Fonseca, L. L., Yang, W. S., Geerts, D., Turkson, J., Ji, J., & Ramos, J. W. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100880 · Cited by 4
NF-κB and Cancer Therapy Drugs
Motolani, A., Martin, M., Sun, M., & Lu, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00064-5 · Cited by 8
Structure and function of the T-cell protein tyrosine phosphatase
Bourdeau, A., Heinonen, K. M., Brunet, D. V., Tailor, P., Lapp, W. S., & Tremblay, M. L. (2003) · Topics in current genetics · doi:10.1007/978-3-540-40035-6_10 · Cited by 4
“For example, specific inhibitors of TC-PTP could delay the activation of NFκB by decreasing IκB activity thus reducing the possibility of skin cancer ( Dajee et al 2003 ).”
BackgroundParzymies, P. (2026) · Experimental Dermatology · doi:10.1111/exd.70293 · Cited by 3
Deregulation of cell-death pathways as the cornerstone of skin diseases
Zutterman, N., Maes, H., Claerhout, S., Agostinis, P., & Garmyn, M. (2009) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2009.03614.x · Cited by 3
An Animal Explant Model for the Study of Human Cutaneous Squamous Cell Carcinoma
Belkin, D. A., Chen, J., Mo, J. L., Rosoff, J. S., Goldenberg, S., Poppas, D. P., Krueger, J. G., Herschman, M., Mitsui, H., Felsen, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076156 · Cited by 3
“For example, Ras-driven human SCC lethally disseminates when cells are injected into the bloodstream but not when they are implanted above a regenerated basement membrane [29,30].”
BackgroundBasement membrane and extracellular matrix molecules in the skin
Tzu, J., Li, J., & Marinkovich, M. P. (2005) · Advances in developmental biology · doi:10.1016/s1574-3349(05)15004-2 · Cited by 4
Self-citationThe c-Rel subunit of NF-κB is a crucial regulator of phenotype and motility of HaCaT keratinocytes
Lorenz, V., Schön, M. P., & Seitz, C. S. (2015) · Archives of Dermatological Research · doi:10.1007/s00403-015-1562-2 · Cited by 5
Integrin α6 targeted cancer imaging and therapy
Zhang, W., Ye, J., Li, X., Li, Y., & Feng, G. (2023) · Visualized Cancer Medicine · doi:10.1051/vcm/2022007 · Cited by 4
Squamous Cell Carcinoma and its Precursors
Gupta, G., & Dirschka, T. (2024) · Wiley eBooks · doi:10.1002/9781119709268.rook140 · Cited by 4
Emerging from NF-κB’s Shadow, SUMOylated IκBα Represses Transcription
Perkins, N. D. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.07.011 · Cited by 2
“Moreover, in normal human epidermal Cancer Cell 24 cells, expression of the IkB SR bypasses oncogenic H-Ras V12 dependent growth arrest, resulting in malignant cells resembling SCC (Dajee et al., 2003).”
BackgroundMolecular Basis of Oncogenesis by NF-κB
Fan, Y., Dutta, J., Gupta, N., & Gélinas, C. (2007) · Springer eBooks · doi:10.1007/0-387-33573-0_9 · Cited by 2
Colegio, O. R., & Leffell, D. J. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1788-4.00002-2 · Cited by 2
Inoue, Y., Shimizu, A., Suto, M., Kishi, C., Takahashi, A., Yasuda, M., Iijima, M., Arakawa, H., & Ishikawa, O. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14482 · Cited by 2
Biology of the Basement Membrane Zone
Hashmi, S., & Marinkovich, M. P. (2015) · Springer eBooks · doi:10.1007/978-3-662-45698-9_1 · Cited by 2
Self-citation[Screening and Identification of Non-Small-Cell Lung Cancer Associated Antigen with SEREX.].
Yue, W., Zhang, L., Zheng, H., Wang, Y., Sun, Y., & Jiao, Z. (2009) · PubMed · doi:10.3779/j.issn.1009-3419.2009.04.06 · Cited by 2
Role of Sphingolipids in Non-melanoma Skin Cancer
Lin, C., & Mao, C. (2015) · Springer eBooks · doi:10.1007/978-3-319-20750-6_5 · Cited by 2
Hemidesmosomes and their Components: Adhesion versus Signaling in Health and Disease
Kligys, K. R., Hamill, K. J., & Jones, J. (2008) · Wiley eBooks · doi:10.1002/9783527622092.ch6 · Cited by 2
NF-κB, IκB Kinase and Interacting Signal Networks in Squamous Cell Carcinomas
Costanzo, A., Spallone, G., & Karin, M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7203-3_10 · Cited by 2
Siegel, D. M., Tanghetti, E. A., Brody, N., Freeman, M., Skov, T., Petersen, A. H., Clonier, F., & Spelman, L. J. (2017) · SKIN The Journal of Cutaneous Medicine · doi:10.25251/skin.1.3.3 · Cited by 2
Cancer Biology: Severe Cumulative Delayed Type Hypersensitivity Reactions
Khatami, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-66475-0_6 · Cited by 4
Beauvais, D. M., Short, K., Stueven, N. A., Nelson, S. E., Lee, D., Jung, O., Anderson, R. A., Lambert, P. F., & Rapraeger, A. C. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/252742 · Cited by 2
DOTA‐Based Plectin‐1 Targeted Contrast Agent Enables Detection of Pancreatic Cancer in Human Tissue
Gazzi, T., Lesina, M., Wang, Q., Berninger, A., Radetzki, S., Demir, İ. E., Kohlmann, L., Meiser, W., Wilke, S., von Kries, J. P., et al. (2024) · Angewandte Chemie · doi:10.1002/ange.202318485 · Cited by 1
Roles of Integrins in the Development and Progression of Squamous Cell Carcinomas
Lamar, J. M., & DiPersio, C. M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7203-3_2 · Cited by 1
“These studies have revealed that a6b4 is critical for SCC formation (Dajee et al. 2003), and that it can promote survival and invasion of SCC and other carcinoma cells (Lipscomb and Mercurio 2005; Marinkovich 2007).”
BackgroundInfluentialNonmelanoma Skin Cancer: Keratinocytic Tumors
Colgan, M. B., Cappel, M. A., Pittelkow, M. R., Fujii, K., Terhorst‐Molawi, D., & Stockfleth, E. (2010) · Springer eBooks · doi:10.1007/978-3-642-05072-5_15 · Cited by 1
Trzonkowski, P. (2009) · Cited by 1
Glick, A. B., & Yuspa, S. H. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4066-6.00041-x · Cited by 1
Harwood, C. A., Proby, C. M., & Arron, S. T. (2016) · Springer eBooks · doi:10.1007/978-3-662-47081-7_3 · Cited by 1
Hutchinson, E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1034 · Cited by 1
Philpott, M. P., Bergamaschi, D., & Storey, A. (2007) · Wiley eBooks · doi:10.1002/9780470025079.chap389 · Cited by 1
RHO Proteins in RAS Signaling and Transformation
Karnoub, A. E., Chenette, E. J., & Der, C. J. (2006) · Springer eBooks · doi:10.1007/1-4020-4708-8_7 · Cited by 2
“A study by Dajee and colleagues suggests that NF- B inhibition may promote, and not prevent, squamous cell carcinoma (Dajee et al., 2003).”
BackgroundMolecular Basis of Oncogenesis by NF-κB: From a Bird's Eye View to a RELevant Role in Cancer
Fan, Y., Dutta, J., Gupta, N., & Gélinas, C. (2013) · Cited by 2
Dynamic Functions of the α6β4 Integrin in Carcinoma
Rabinovitz, I., & Mercurio, A. M. (2006) · Springer eBooks · doi:10.1007/1-4020-4009-1_8 · Cited by 1
Martínez, I. (2007) · D-Scholarship@Pitt (University of Pittsburgh)
'The Role of Brm, Brg-1, Snail 1 and Snail 2 in the Progression of Non-Melanoma Skin Cancer'
Bock, V. L. (2008) · The Sydney eScholarship Repository (The University of Sydney)
NF-kappaB in skin immune homeostasis and cancer development
Ulvmar, M. H. (2009) · Figshare
Nuclear Factor‐κB in Apoptosis and Tumorigenesis
Greten, F. R., & Karin, M. (2006) · Wiley eBooks · doi:10.1002/9783527619665.ch16
NF-ĸB mediated signaling mechanisms in epidermal homeostasis and carcinogenesis
Lorenz, V. (2013) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4050
Lindström, E. (2008) · Figshare
Matrix metalloproteinases as biomarkers in premalignant and malignant tumors of the human skin
Kuivanen, T. (2008) · Helda - University of Helsinki Institutional Repository
Replication and the Cell Cycle
Richardson, H. E., Quinn, L. M., Amin, N., Herr, A., Brumby, A. M., Doyle, K. M., Humbert, P. O., & Secombe, J. (2006) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200500022 · Cited by 1
The role of genetic factors in breast cancer aetiology
Hammond, V. (2010) · ePrints Soton (University of Southampton)
Gong, C. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_10
“NF-κB blockage also triggered invasive human epidermal neoplasia (Dajee et al., 2003).”
BackgroundGenetic Determinants of Susceptibility to UV Light-Associated Skin Cancer
Sprecher, E. (2004) · Exogenous Dermatology · doi:10.1159/000091899
“These models already led to important advances in our understanding of skin cancer, for example the role played by various components of the basement membrane in the process of skin cancer progression [ ,”
BackgroundAbsence of Somatic Mutations of NEMO in Keratoacanthoma
Ridd, K., Vemula, S. S., & Bastian, B. C. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.109
“Silencing of the NF-kB pathway is required for RAS-induced tumorigenesis in a xenograft model (Dajee et al., 2003).”
BackgroundMethodThe novel sumoylation enhancer RSUME is implicated in pituitary tumour pathogenesis
Shan, B. (2010) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0030-1266992
Metadata
- Authors
- Dajee, M., Lazarov, M., Zhang, J. Y., Cai, T., Green, C. L., Russell, A. J., Marinkovich, M. P., Tao, S., Lin, Q., Kubo, Y., & Khavari, P. A.
- Affiliations
- VA Palo Alto Health Care System (US)
- Corresponding author
- Khavari, Paul A.
- ORCID
- Venue
- Nature
- Published
- 2003-02
- Volume
- 421
- Issue
- 6923
- Pages
- 639-643
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1986301169
- Cited by
- 535
- References
- 32
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 12 · 2023: 10 · 2022: 7 · 2021: 11 · 2020: 9 · 2019: 12 · 2018: 13 · 2017: 7 · 2016: 20 · 2015: 21 · 2014: 22 · 2013: 25 · 2012: 23
- FWCI
- 19.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Office of Research and Development
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- NF-κB, oncogenic Ras, IκBα, cell cycle arrest, laminin-5, alpha6beta4 integrin, carcinogenesis, skin cancer
- MeSH terms
- NF-KappaB Inhibitor alpha, Kalinin, Animals, Cell Division, Epidermis, Humans, Mice, Nude, Neoplasm Invasiveness, Neoplasms, Genes, ras, Transduction, Genetic, Keratinocytes, Oncogene Protein p21(ras), Cell Adhesion Molecules, NF-kappa B, Mice, SCID, Telomere, Apoptosis, Cyclin-Dependent Kinases, I-kappa B Proteins, Integrin alpha6beta4, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.